Microbes and Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 51, Issue 4, 2016, Pages 979-984

  Itzhaki, Ruth F ^a,ae   Lathe, Richard ^b   Balin, Brian J ^c   Ball, Melvyn J ^d   Bearer, Elaine L ^e   Braak, Heiko ^f   Bullido, Maria J ^g   Carter, Chris ^h   Clerici, Mario ⁱ   Cosby, S Louise ^j   Del Tredici, Kelly ^f   Field, Hugh ^k   Fulop, Tamas ^l   Grassi, Claudio ^m,n   Griffin, W Sue T ^o   Haas, Jürgen ^b   Hudson, Alan P ^p   Kamer, Angela R ^q   Kell, Douglas B ^a   Licastro, Federico ^r   Letenneur, Luc ^s   Lövheim, Hugo ^t   Mancuso, Roberta ^u   Miklossy, Judith ^v   Otth, Carola ^w   Palamara, Anna Teresa ^x   Perry, George ^y   Preston, Christopher ^z   Pretorius, Etheresia ^aa   Strandberg, Timo ^ab   Tabet, Naji ^ac   Taylor Robinson, Simon D ^ad   Whittum Hudson, Judith A ^p   more..

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c PHILADELPHIA COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^f UNIVERSITY OF ULM   (Germany)

^g UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^h PolygenicPathways   (United Kingdom)

ⁱ UNIVERSITY OF MILAN   (Italy)

^j QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^k QUEENS COLLEGE   (United Kingdom)

^l UNIVERSITÉ DE SHERBROOKE   (Canada)

^m CATHOLIC UNIVERSITY   (Italy)

ⁿ IRCCS SAN RAFFAELE PISANA   (Italy)

^o UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^p WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^q NEW YORK UNIVERSITY COLLEGE OF DENTISTRY   (United States)

^r UNIVERSITY OF BOLOGNA   (Italy)

^s UNIVERSITÉ DE BORDEAUX   (France)

^t UMEÅ UNIVERSITY   (Sweden)

^u IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

^v Alzheimer Research Center Prevention Alzheimer International Foundation   (Switzerland)

^w UNIVERSIDAD AUSTRAL DE CHILE   (Chile)

^x SAPIENZA UNIVERSITY OF ROME   (Italy)

^y University of San Antonio   (United States)

^z INSTITUTE OF VIROLOGY   (United Kingdom)

^aa UNIVERSITY OF PRETORIA   (South Africa)

^ab HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^ac BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

^ad ST MARY S HOSPITAL   (United Kingdom)

^ae UNIVERSITY OF OXFORD   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; CHLAMYDIA PNEUMONIAE; CHLAMYDIAL PNEUMONIA; DISEASE COURSE; HERPES SIMPLEX; HERPES SIMPLEX ENCEPHALITIS; HERPES SIMPLEX VIRUS 1; HUMAN; MICROORGANISM; MYCOSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SPIROCHETE; SPIROCHETE INFECTION; ANIMAL; BRAIN; COMMUNICABLE DISEASE; COMPLICATION; METABOLISM; MICROBIOLOGY; MICROFLORA; PATHOLOGY;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BRAIN; COMMUNICABLE DISEASES; HUMANS; MICROBIOTA;

EID: 84964820947     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-160152     Document Type: Review

References (79)

1. De Chiara G, Marcocci ME, Sgarbanti R, Civitelli L, Ripoli C, Piacentini R, Garaci E, Grassi C, Palamara AT (2012) Infectious agents and neurodegeneration. Mol Neurobiol 46, 614 - 638
2. Itzhaki RF (2014) Herpes simplex virus type 1 and Alzheimer's disease: Increasing evidence for a major role of the virus. Front Aging Neurosci 6, 202
3. Balin BJ, Hudson AP (2014) Etiology and pathogenesis of late-onset Alzheimer's disease. Curr Allergy Asthma Rep 14, 417
4. Miklossy J (2015) Historic evidence to support a causal relationship between spirochetal infections and Alzheimer's disease. Front Aging Neurosci 7, 46
5. Alonso R, Pisa D, Marina AI, Morato E, Rabano A, Carrasco L (2014) Fungal infection in patients with Alzheimer's disease. J Alzheimers Dis 41, 301 - 311
6. Pisa D, Alonso R, Rabano A, Rodal I, Carrasco L (2015) Different brain regions are infected with fungi in Alzheimer's disease. Sci Rep 5, 15015
7. Potgieter M, Bester J, Kell DB, Pretorius E (2015) The dormant blood microbiome in chronic, inflammatory diseases. FEMS Microbiol Rev 39, 567 - 591
8. Jamieson GA, Maitland NJ, Wilcock GK, Craske J, Itzhaki RF (1991) Latent herpes simplex virus type 1 in normal and Alzheimer's disease brains. J Med Virol 33, 224 - 227
9. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van BG, Berg L (1991) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41, 479 - 486
10. Braak H, Braak E (1991) Neuropathological staging of Alzheimer-related changes. Acta Neuropathol (Berl) 82, 239 - 259
11. Jamieson GA, Maitland NJ, Wilcock GK, Craske J, Itzhaki RF (1991) Latent herpes simplex virus type 1 in normal and Alzheimer's disease brains. J Med Virol 33, 224 - 227
12. Miklossy J (1993) Alzheimer's disease -A spirochetosis?. Neuroreport 4, 841 - 848
13. Balin BJ, Gerard HC, Arking EJ, Appelt DM, Branigan PJ, Abrams JT, Whittum-Hudson JA, Hudson AP (1998) Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain. Med Microbiol Immunol 187, 23 - 42
14. Saldanha J, Sutton RN, Gannicliffe A, Farragher B, Itzhaki RF (1986) Detection of HSV1 DNA by in situ hybridisation in human brain after immunosuppression. J Neurol Neurosurg Psychiatry 49, 613 - 619
15. Roos KL (2014) Encephalitis. Handb Clin Neurol 121, 1377 - 1381
16. Miklossy J, Khalili K, Gern L, Ericson RL, Darekar P, Bolle L, Hurlimann J, Paster BJ (2004) Borrelia burgdorferi persists in the brain in chronic lyme neuroborreliosis and may be associated with Alzheimer disease. J Alzheimers Dis 6, 639 - 649
17. Wozniak MA, Mee AP, Itzhaki RF (2009) Herpes simplex virus type 1 DNA is located within Alzheimer's disease amyloid plaques. J Pathol 217, 131 - 138
18. Letenneur L, Peres K, Fleury H, Garrigue I, Barberger-Gateau P, Helmer C, Orgogozo JM, Gauthier S, Dartigues JF (2008) Seropositivity to herpes simplex virus antibodies and risk of Alzheimer's disease: A population-based cohort study. PLoS One 3, e3637
19. Mancuso R, Baglio F, Cabinio M, Calabrese E, Hernis A, Nemni R, Clerici M (2014) Titers of herpes simplex virus type 1 antibodies positively correlate with grey matter volumes in Alzheimer's disease. J Alzheimers Dis 38, 741 - 745
20. Lövheim H, Gilthorpe J, Johansson A, Eriksson S, Hallmans G, Elgh F (2015) Herpes simplex infection and the risk of Alzheimer's disease: A nested case-control study. Alzheimers Dement 11, 587 - 592
21. Lövheim H, Gilthorpe J, Adolfsson R, Nilsson LG, Elgh F (2015) Reactivated herpes simplex infection increases the risk of Alzheimer's disease. Alzheimers Dement 11, 593 - 599
22. Wyss-Coray T, Rogers J (2012) Inflammation in Alzheimer disease -a brief review of the basic science and clinical literature. Cold Spring Harb Perspect Med 2, a006346
23. Stefaniak J, O'Brien J (2015) Imaging of neuroinflammation in dementia: A review. J Neurol Neurosurg Psychiatry 87, 21 - 28
24. Mahley RW, Weisgraber KH, Huang Y (2009) Apolipoprotein E: Structure determines function, from atherosclerosis to Alzheimer's disease to AIDS. J Lipid Res 50 (Suppl), S183 - S188
25. Verghese PB, Castellano JM, Holtzman DM (2011) Apolipoprotein E in Alzheimer's disease and other neurological disorders. Lancet Neurol 10, 241 - 252
26. Yu JT, Tan L, Hardy J (2014) Apolipoprotein E in Alzheimer's disease: An update. Annu Rev Neurosci 37, 79 - 100
27. Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, Combarros O, Zelenika D, Bullido MJ, Tavernier B, Letenneur L, Bettens K, Berr C, Pasquier F, Fievet N, Barberger-Gateau P, Engelborghs S, De DP, Mateo I, Franck A, Helisalmi S, Porcellini E, Hanon O, de Pancorbo MM, Lendon C, Dufouil C, Jaillard C, Leveillard T, Alvarez V, Bosco P, Mancuso M, Panza F, Nacmias B, Bossu P, Piccardi P, Annoni G, Seripa D, Galimberti D, Hannequin D, Licastro F, Soininen H, Ritchie K, Blanche H, Dartigues JF, Tzourio C, Gut I, Van BC, Alperovitch A, Lathrop M, Amouyel P (2009) Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 41, 1094 - 1099
28. Porcellini E, Carbone I, Ianni M, Licastro F (2010) Alzheimer's disease gene signature says: Beware of brain viral infections. Immun Ageing 7, 16
29. Carter CJ (2010) APP, APOE, complement receptor 1, clusterin and PICALM and their involvement in the herpes simplex life cycle. Neurosci Lett 483, 96 - 100
30. Lambert JC, Zelenika D, Hiltunen M, Chouraki V, Combarros O, Bullido MJ, Tognoni G, Fievet N, Boland A, Arosio B, Coto E, Del ZM, Mateo I, Frank-Garcia A, Helisalmi S, Porcellini E, Pilotto A, Forti P, Ferri R, Delepine M, Scarpini E, Siciliano G, Solfrizzi V, Sorbi S, Spalletta G, Ravaglia G, Valdivieso F, Alvarez V, Bosco P, Mancuso M, Panza F, Nacmias B, Bossu P, Piccardi P, Annoni G, Seripa D, Galimberti D, Licastro F, Lathrop M, Soininen H, Amouyel P (2011) Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populations. Neurobiol Aging 32, 756. e11-e15
31. Licastro F, Carbone I, Ianni M, Porcellini E (2011) Gene signature in Alzheimer's disease and environmental factors: The virus chronicle. J Alzheimers Dis 27, 809 - 817
32. Carter CJ (2013) Susceptibility genes are enriched in those of the herpes simplex virus 1/host interactome in psychiatric and neurological disorders. Pathog Dis 69, 240 - 261
33. Baker HF, Ridley RM, Duchen LW, Crow TJ, Bruton CJ (1994) Induction of beta (A4)-amyloid in primates by injection of Alzheimer's disease brain homogenate. Comparison with transmission of spongiform encephalopathy. Mol Neurobiol 8, 25 - 39
34. Ridley RM, Baker HF, Windle CP, Cummings RM (2006) Very long term studies of the seeding of beta-amyloidosis in primates. J Neural Transm 113, 1243 - 1251
35. Kane MD, Lipinski WJ, Callahan MJ, Bian F, Durham RA, Schwarz RD, Roher AE, Walker LC (2000) Evidence for seeding of beta-amyloid by intracerebral infusion of Alzheimer brain extracts in beta-amyloid precursor protein-transgenic mice. J Neurosci 20, 3606 - 3611
36. Meyer-Luehmann M, Coomaraswamy J, Bolmont T, Kaeser S, Schaefer C, Kilger E, Neuenschwander A, Abramowski D, Frey P, Jaton AL, Vigouret JM, Paganetti P, Walsh DM, Mathews PM, Ghiso J, Staufenbiel M, Walker LC, Jucker M (2006) Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science 313, 1781 - 1784
37. Stanley LC, Mrak RE, Woody RC, Perrot LJ, Zhang S, Marshak DR, Nelson SJ, Griffin WS (1994) Glial cytokines as neuropathogenic factors in HIV infection: Pathogenic similarities to Alzheimer's disease. J Neuropathol Exp Neurol 53, 231 - 238
38. Esiri MM, Biddolph SC, Morris CS (1998) Prevalence of Alzheimer plaques in AIDS. J Neurol Neurosurg Psychiatry 65, 29 - 33
39. Green DA, Masliah E, Vinters HV, Beizai P, Moore DJ, Achim CL (2005) Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients. AIDS 19, 407 - 411
40. Bearer EL, Woltjer R, Donahue JE, Kilpatrick K (2013) Herpes encephalitis and Abeta plaques. FASEB J 27,. 873.16
41. Smith DB, Simmonds P, Bell JE (2014) Brain viral burden, neuroinflammation and neurodegeneration in HAART-treated HIV positive injecting drug users. J Neurovirol 20, 28 - 38
42. McQuaid S, Allen IV, McMahon J, Kirk J (1994) Association of measles virus with neurofibrillary tangles in subacute sclerosing panencephalitis: A combined in situ hybridization and immunocytochemical investigation. Neuropathol Appl Neurobiol 20, 103 - 110
43. Wozniak MA, Itzhaki RF, Shipley SJ, Dobson CB (2007) Herpes simplex virus infection causes cellular beta-amyloid accumulation and secretase upregulation. Neurosci Lett 429, 95 - 100
44. Wozniak MA, Frost AL, Itzhaki RF (2009) Alzheimer's disease-specific tau phosphorylation is induced by herpes simplex virus type 1. J Alzheimers Dis 16, 341 - 350
45. Zambrano A, Solis L, Salvadores N, Cortes M, Lerchundi R, Otth C (2008) Neuronal cytoskeletal dynamic modification and neurodegeneration induced by infection with herpes simplex virus type 1. J Alzheimers Dis 14, 259 - 269
46. De Chiara G, Marcocci ME, Civitelli L, Argnani R, Piacentini R, Ripoli C, Manservigi R, Grassi C, Garaci E, Palamara AT (2010) APP processing induced by herpes simplex virus type 1 (HSV-1) yields several APP fragments in human and rat neuronal cells. PLoS One 5, e13989
47. Lerchundi R, Neira R, Valdivia S, Vio K, Concha MI, Zambrano A, Otth C (2011) Tau cleavage at D421 by caspase-3 is induced in neurons and astrocytes infected with herpes simplex virus type 1. J Alzheimers Dis 23, 513 - 520
48. Ill-Raga G, Palomer E, Wozniak MA, Ramos-Fernandez E, Bosch-Morato M, Tajes M, Guix FX, Galan JJ, Clarimon J, Antunez C, Real LM, Boada M, Itzhaki RF, Fandos C, Munoz FJ (2011) Activation of PKR causes amyloid beta-peptide accumulation via de-repression of BACE1 expression. PLoS One 6, e21456
49. Santana S, Recuero M, Bullido MJ, Valdivieso F, Aldudo J (2012) Herpes simplex virus type I induces the accumulation of intracellular beta-amyloid in autophagic compartments and the inhibition of the non-amyloidogenic pathway in human neuroblastoma cells. Neurobiol Aging 33, 430 - 433
50. Martin C, Aguila B, Araya P, Vio K, Valdivia S, Zambrano A, Concha MI, Otth C (2014) Inflammatory and neurodegeneration markers during asymptomatic HSV-1 reactivation. J Alzheimers Dis 39, 849 - 859
51. Civitelli L, Marcocci ME, Celestino I, Piacentini R, Garaci E, Grassi C, De Chiara G, Palamara AT (2015) Herpes simplex virus type 1 infection in neurons leads to production and nuclear localization of APP intracellular domain (AICD): Implications for Alzheimer's disease pathogenesis. J Neurovirol 21, 480 - 490
52. Piacentini R, Li Puma DD, Ripoli C, Marcocci ME, De Chiara G, Garaci E, Palamara AT, Grassi C (2015) Herpes simplex virus type-1 infection induces synaptic dysfunction in cultured cortical neurons via GSK-3 activation and intraneuronal amyloid-beta protein accumulation. Sci Rep 5, 15444
53. Little CS, Hammond CJ, MacIntyre A, Balin BJ, Appelt DM (2004) Chlamydia pneumoniae induces Alzheimer-like amyloid plaques in brains of BALB/c mice. Neurobiol Aging 25, 419 - 429
54. Miklossy J, Kis A, Radenovic A, Miller L, Forro L, Martins R, Reiss K, Darbinian N, Darekar P, Mihaly L, Khalili K (2006) Beta-amyloid deposition and Alzheimer's type changes induced by Borrelia spirochetes. Neurobiol Aging 27, 228 - 236
55. Boelen E, Stassen FR, van der Ven AJ, Lemmens MA, Steinbusch HP, Bruggeman CA, Schmitz C, Steinbusch HW (2007) Detection of amyloid beta aggregates in the brain of BALB/c mice after Chlamydia pneumoniae infection. Acta Neuropathol 114, 255 - 261
56. Cheng SB, Ferland P, Webster P, Bearer EL (2011) Herpes simplex virus dances with amyloid precursor protein while exiting the cell. PLoS One 6, e17966
57. Wozniak MA, Frost AL, Preston CM, Itzhaki RF (2011) Antivirals reduce the formation of key Alzheimer's disease molecules in cell cultures acutely infected with herpes simplex virus type 1. PLoS One 6, e25152
58. Velayudhan L, Gasper A, Pritchard M, Baillon S, Messer C, Proitsi P (2015) Pattern of smell identification impairment in Alzheimer's disease. J Alzheimers Dis 46, 381 - 387
59. Braak H, Braak E, Bohl J (1993) Staging of Alzheimer-related cortical destruction. Eur Neurol 33, 403 - 408
60. Ball MJ, Lukiw WJ, Kammerman EM, Hill JM (2013) Intracerebral propagation of Alzheimer's disease: Strengthening evidence of a herpes simplex virus etiology. Alzheimers Dement 9, 169 - 175
61. Mori I, Nishiyama Y, Yokochi T, Kimura Y (2005) Olfactory transmission of neurotropic viruses. J Neurovirol 11, 129 - 137
62. Gillet L, Frederico B, Stevenson PG (2015) Host entry by gamma-herpesviruses -lessons from animal viruses?. Curr Opin Virol 15, 34 - 40
63. Little CS, Bowe A, Lin R, Litsky J, Fogel RM, Balin BJ, Fresa-Dillon KL (2005) Age alterations in extent and severity of experimental intranasal infection with Chlamydophila pneumoniae in BALB/c mice. Infect Immun 73, 1723 - 1734
64. Braak H Del Tredici K (2015) The preclinical phase of the pathological process underlying sporadic Alzheimer's disease. Brain 138, 2814 - 2833
65. Blanc M, Hsieh WY, Robertson KA, Kropp KA, Forster T, Shui G, Lacaze P, Watterson S, Griffiths SJ, Spann NJ, Meljon A, Talbot S, Krishnan K, Covey DF, Wenk MR, Craigon M, Ruzsics Z, Haas J, Angulo A, Griffiths WJ, Glass CK, Wang Y, Ghazal P (2013) The transcription factor STAT-1 couples macrophage synthesis of 25-hydroxycholesterol to the interferon antiviral response. Immunity 38, 106 - 118
66. Liu SY, Aliyari R, Chikere K, Li G, Marsden MD, Smith JK, Pernet O, Guo H, Nusbaum R, Zack JA, Freiberg AN, Su L, Lee B, Cheng G (2013) Interferon-inducible cholesterol-25-hydroxylase broadly inhibits viral entry by production of 25-hydroxycholesterol. Immunity 38, 92 - 105
67. Papassotiropoulos A, Lambert JC, Wavrant-De Vrieze F, Wollmer MA, von der KH, Streffer JR, Maddalena A, Huynh KD, Wolleb S, Lutjohann D, Schneider B, Thal DR, Grimaldi LM, Tsolaki M, Kapaki E, Ravid R, Konietzko U, Hegi T, Pasch T, Jung H, Braak H, Amouyel P, Rogaev EI, Hardy J, Hock C, Nitsch RM (2005) Cholesterol 25-hydroxylase on chromosome 10q is a susceptibility gene for sporadic Alzheimer's disease. Neurodegener Dis 2, 233 - 241
68. Lathe R, Sapronova S, Kotelevtsev Y (2014) Atherosclerosis and Alzheimer -diseases with a common cause? Inflammation, oxysterols, vasculature. BMC Geriatrics 14, 36
69. Soscia SJ, Kirby JE, Washicosky KJ, Tucker SM, Ingelsson M, Hyman B, Burton MA, Goldstein LE, Duong S, Tanzi RE, Moir RD (2010) The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide. PLoS One 5, e9505
70. White MR, Kandel R, Tripathi S, Condon D, Qi L, Taubenberger J, Hartshorn KL (2014) Alzheimer's associated beta-amyloid protein inhibits influenza A virus and modulates viral interactions with phagocytes. PLoS One 9, e101364
71. Bourgade K, Garneau H, Giroux G, Le Page Y, Bocti C, Dupuis G, Frost EH, Fulop T Jr (2015) Beta-amyloid peptides display protective activity against the human Alzheimer's disease-associated herpes simplex virus-1. Biogerontology 16, 85 - 98
72. Bourgade K, Le PA, Bocti C, Witkowski JM, Dupuis G, Frost EH, Fulop T Jr (2016) Protective effect of amyloid-beta peptides against herpes simplex virus-1 infection in a neuronal cell culture model. J Alzheimers Dis 50, 1227 - 1241
73. Williams WM, Torres S, Siedlak SL, Castellani RJ, Perry G, Smith MA, Zhu X (2013) Antimicrobial peptide beta-defensin-1 expression is upregulated in Alzheimer's brain. J Neuroinflammation 10, 127
74. Itzhaki RF, Lin WR, Shang D, Wilcock GK, Faragher B, Jamieson GA (1997) Herpes simplex virus type 1 in brain and risk of Alzheimer's disease. Lancet 349, 241 ? 244
75. Itzhaki RF, Lin WR, Shang D, Wilcock GK, Faragher B, Jamieson GA (1997) Herpes simplex virus type 1 in brain and risk of Alzheimer's disease. Lancet 349, 241 244
76. Marques AR, Straus SE, Fahle G, Weir S, Csako G, Fischer SH (2001) Lack of association between HSV-1 DNA in the brain, Alzheimer's disease and apolipoprotein E4. J Neurovirol 7, 82 - 83
77. Hemling N, Roytta M, Rinne J, Pollanen P, Broberg E, Tapio V, Vahlberg T, Hukkanen V (2003) Herpesviruses in brains in Alzheimer's and Parkinson's diseases. Ann Neurol 54, 267 - 271
78. Beffert U, Bertrand P, Champagne D, Gauthier S, Poirier J (1998) HSV-1 in brain and risk of Alzheimer's disease. Lancet 351, 1330 - 1331
79. Cummings JL, Morstorf T, Zhong K (2014) Alzheimer's disease drug-development pipeline: Few candidates, frequent failures. Alzheimers Res Ther 6, 37.